A critical appraisal of the ATLAS trial of maintenance therapy for multiple myeloma: end points, censoring and equipoise

Ghulam Rehman Mohyuddin; Tomer Meirson

doi:10.1038/s41571-023-00801-x

A critical appraisal of the ATLAS trial of maintenance therapy for multiple myeloma: end points, censoring and equipoise

Ghulam Rehman Mohyuddin, Tomer Meirson

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Pages (from-to)	735-736
Number of pages	2
Journal	Nature Reviews Clinical Oncology
Volume	20
Issue number	11
Early online date	11 Jul 2023
DOIs	https://doi.org/10.1038/s41571-023-00801-x
State	Published - Nov 2023
Externally published	Yes

Bibliographical note

Funding Information:
The authors acknowledge R. Mutai for his assistance with the censoring analysis discussed in this article.

Funding

The authors acknowledge R. Mutai for his assistance with the censoring analysis discussed in this article.

Access to Document

10.1038/s41571-023-00801-x

Cite this

@article{32b6c3b4f9884d37b7dec0681aee464b,

title = "A critical appraisal of the ATLAS trial of maintenance therapy for multiple myeloma: end points, censoring and equipoise",

author = "Mohyuddin, {Ghulam Rehman} and Tomer Meirson",

note = "Funding Information: The authors acknowledge R. Mutai for his assistance with the censoring analysis discussed in this article.",

year = "2023",

month = nov,

doi = "10.1038/s41571-023-00801-x",

language = "אנגלית",

volume = "20",

pages = "735--736",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

publisher = "Nature Publishing Group",

number = "11",

}

TY - JOUR

T1 - A critical appraisal of the ATLAS trial of maintenance therapy for multiple myeloma

T2 - end points, censoring and equipoise

AU - Mohyuddin, Ghulam Rehman

AU - Meirson, Tomer

N1 - Funding Information: The authors acknowledge R. Mutai for his assistance with the censoring analysis discussed in this article.

PY - 2023/11

Y1 - 2023/11

UR - http://www.scopus.com/inward/record.url?scp=85164676768&partnerID=8YFLogxK

U2 - 10.1038/s41571-023-00801-x

DO - 10.1038/s41571-023-00801-x

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 37433885

AN - SCOPUS:85164676768

SN - 1759-4774

VL - 20

SP - 735

EP - 736

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

IS - 11

ER -

A critical appraisal of the ATLAS trial of maintenance therapy for multiple myeloma: end points, censoring and equipoise

Bibliographical note

Funding

Access to Document

Other files and links

Cite this